Clinical Trials Directory

Trials / Completed

CompletedNCT04918394

Mold Exposure and Impact on Asthma Control in French Asthmatic Children

Assessment of Mold Exposure in Asthmatic Children Follow-up in Nord and Pas-De-Calais Departments, France, and Impact on Asthma Control

Status
Completed
Phase
Study type
Observational
Enrollment
451 (actual)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
1 Year – 18 Years
Healthy volunteers
Not accepted

Summary

Observational, multicenter, study conducted in 12 hospitals in the Nord and Pas-De-Calais departments. The aim of this study is to describe the relationship between reported exposure to molds and asthma control in a pediatric population. Each patient followed by a specialized asthma pediatrician in one of the study center will be proposed to participate in the study. Children aged 1 to \< 18 years, with asthma diagnosis, based on the assessment of a specialized physician after a follow-up of at least 6 months Inclusion, non-inclusion and exclusion criteria will be verified by the investigators. The questionnaires will be completed during the consultation, collected by the physician in charge of the consultation and sent to the principal investigator for data entry. Inclusion will take place over a period of 12 consecutive months from the date of obtaining regulatory approval.

Conditions

Interventions

TypeNameDescription
OTHERQuestionnaire of Mold / moisture exposureMold / moisture exposure is assessed by the 5 following questions, whose positive response has been associated with the actual presence of mold in the household (according to data from the literature data), asked in the form of a parent-completed declarative questionnaire regarding the child's primary living home: * Presence of visible mold * Impression of dampness * Apparent dampness * Existence of recent water damage in the last year * Presence of a moldy odor

Timeline

Start date
2020-06-10
Primary completion
2021-08-20
Completion
2021-08-20
First posted
2021-06-08
Last updated
2022-04-06

Locations

10 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04918394. Inclusion in this directory is not an endorsement.